Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1573-2568
    Keywords: AMMONIA ; MONOCHLORAMINE ; GASTRIC MUCOSAL LESIONS ; POLAPREZINC ; ZINC L-CARNOSINE ; SUCRALFATE ; H. PYLORI
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Effects of a novel zinc compound polaprezinc[N-(3-aminopropionyl)-L-histidinatozinc] and sucralfateon the mucosal ulcerogenic responses induced bymonochloramine (NH2Cl) were examined in ratstomachs. Oral administration of NH2Cl (≥60mM) produced severe lesions in unanesthetized ratstomachs, with concomitant increase of lipidperoxidation. These lesions were aggravated by sensorydeafferentation but not affected by pretreatment with indomethacinor L-NAME. The mucosal ulcerogenic response toNH2Cl was significantly inhibited by oralpretreatment with either dmPGE2 (10μg/kg), capsaicin (30 mg/kg), or NOR-3 (3 mg/kg), the NO donor. Gastriclesions induced by NH2Cl were also inhibitedby prior oral administration of polaprezinc (3-30 mg/kg)as well as sucralfate (30 and 100 mg/kg). The protectiveeffect of polaprezinc was not affected by anypretreatments such as indomethacin, L-NAME, or sensorydeafferentation, while that of sucralfate wassignificantly mitigated in the presence of eitherindomethacin or L-NAME. On the other hand, mucosal exposureto NH2OH (60 mM) caused a marked PD reductionin ex vivo stomachs made ischemic by bleeding from thecarotid artery, followed by severe gastric lesions.These ulcerogenic and PD responses caused by NH OHplus ischemia were also attenuated by prior applicationof polaprezinc, while dmPGE2 and sucralfateprevented such lesions without affecting the reduced PDresponse. These results suggest that: (1)NH2Cl generated either exogenously orendogenously damages the gastric mucosa, (2) bothpolaprezinc and sucralfate protect the stomach againstinjury caused by NH2Cl, and (3) the mechanisms underlying the protectiveaction of sucralfate may be partly mediated by bothendogenous PGs and NO but may be different from those ofpolaprezinc.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1573-2568
    Keywords: PROKINETIC DRUG ; GASTRIC MOTILITY ; GASTRIC LESION ; PROSTAGLANDIN DEFICIENCY
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract The present study was performed to examinewhether gastric prokinetic drugs may induce damage inthe rat stomach under normal and prostaglandin(PG)-deficient conditions. Male SD rats fasted for 18 hrwere administered subcutaneously with threedifferent prokinetic drugs such as metoclopramide (3-60mg/kg), ondansetron (0.3-3 mg/kg), and cisapride (3-30mg/kg). Half the number of these animals were pretreated with indomethacin (5 mg/kg) subcutaneously forinduction of PG deficiency in the stomach.Administration of these drugs increased gastric motoractivity in a dose-dependent manner and expeditedgastric emptying at lower doses than those affectinggastric motility; the potency of the hypermotilityeffect was in the following order: metoclopramide =ondansetron 〉 cisapride. None of these drugs alonecaused gross damage in the stomach, although whitishrough areas were observed in the gastric mucosa alongthe folds. In the rats pretreated with indomethacin,however, both metoclopramide and ondansetron provoked multiple hemorrhagic lesions in the gastricmucosa. Indomethacin at this dose showed over 90%inhibition of cyclooxygenase activity without causingany damage in the stomach, and this PG-deficient effect was not affected by coadministration with theprokinetic drugs. The mucosal ulcerogenic responsesinduced by metoclopramide in the presence ofindomethacin were significantly inhibited by prioradministration of atropine (1 mg/kg) or PGE2 (300μg/kg) at doses that inhibited gastric hypermotilityinduced by metoclopramide. These results suggest that:(1) gastric prokinetic drugs induce damage in ratstomachs under PG-deficient conditions at the doses that enhance gastric motility and emptying but notat the doses that expedite gastric emptying only, and(2) gastric hypermotility has the potential to causegross damage in the stomach, supporting the importance of gastric motility as a pathogenic element ofgastric lesions.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...